Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Collins

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Journal of Medicinal Chemistry|April 13, 2001
Pharmacophore analysis of the nuclear oxysterol receptor LXRalphaT A Spencer, D Li, J S Russel, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 1997
A genetic animal model of human neocortical heterotopia associated with seizuresK S Lee, F Schottler, J L Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotectiveK K Wang, R Nath, A Posner, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonistM A Sanner, T A Chappie, A R Dunaiskis, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Journal of Medicinal Chemistry|April 13, 2001
Pharmacophore analysis of the nuclear oxysterol receptor LXRalphaT A Spencer, D Li, J S Russel, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 1997
A genetic animal model of human neocortical heterotopia associated with seizuresK S Lee, F Schottler, J L Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotectiveK K Wang, R Nath, A Posner, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonistM A Sanner, T A Chappie, A R Dunaiskis, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Pageof 14